Offer - Urjas Oil for just ₹ 1 X
Ikgdar, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Other than this, Ikgdar has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Ikgdar is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Ikgdar are Weakness. While these are the most often observed Ikgdar side effects, there are can be others also. These have been listed below. These side effects of Ikgdar are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Ikgdar is Moderate for pregnant women and Severe for women who are breastfeeding. It is important to know if Ikgdar has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ikgdar related warnings section.
Individuals suffering from medical conditions like Hyperkalemia must refrain from the use of Ikgdar since this can cause severe adverse effects. The section on Ikgdar contraindications lists all such conditions.
Additionally, Ikgdar may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Ikgdar is considered not safe while driving, and is not addictive.
Ikgdar is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ikgdar safe for pregnant women?
Pregnant women may experience moderate side effects from Ikgdar. It is best to stop taking Ikgdar immediately and inform your doctor if you notice any discomfort.
Is the use of Ikgdar safe during breastfeeding?
Taking Ikgdar may lead to serious side effects if you are breastfeeding. Ikgdar should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Ikgdar on the Kidneys?
Ikgdar can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ikgdar on the Liver?
Using Ikgdar does not have any harmful effects on the liver.
What is the effect of Ikgdar on the Heart?
The heart can be affected by Ikgdar. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Ikgdar should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ikgdar unless your doctor advises you to do so -
Is this Ikgdar habit forming or addictive?
No, you will not get addicted to Ikgdar.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ikgdar, you should not drive or work on any heavy machine, as Ikgdar can make you drowsy.
Is it safe?
Yes, but take Ikgdar only as per medical advice.
Is it able to treat mental disorders?
No, Ikgdar cannot treat any kind of mental disorder.
Interaction between Food and Ikgdar
It is safe to take Ikgdar with food.
Interaction between Alcohol and Ikgdar
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Ikgdar.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872